Episodes
-
Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 2 of a 3-Part Series
November 22nd, 2024 | Season 1 | 58 mins 36 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the optimal management of chronic lymphocytic leukemia with Dr Nicole Lamanna, moderated by Dr Neil Love. Produced by Research To Practice.
-
The Implications of Recent Datasets for the Current and Future Management of Lung Cancer — A Review of Information from ESMO Congress 2024 and Other Conferences
November 22nd, 2024 | Season 1 | 1 hr 11 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion of the implications of recent datasets for the management of lung cancer, with Drs Ramalingam and Riely, moderated by Dr Neil Love. Produced by Research To Practice.
-
Optimizing the Management of Tenosynovial Giant Cell Tumor
November 20th, 2024 | Season 1 | 1 hr 3 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the management of tenosynovial giant cell tumor with Dr Emanuela Palmerini, moderated by Dr Neil Love. Produced by Research To Practice.
-
Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care — Prostate Cancer
November 20th, 2024 | Season 1 | 57 mins 10 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring discussions with specialists on optimal management and the potential role of investigational approaches for prostate cancer, moderated by Dr Neil Love. Produced by Research To Practice.
-
Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care — Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
November 20th, 2024 | Season 1 | 56 mins 11 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring discussions on optimal management and investigational approaches for non-Hodgkin lymphoma and chronic lymphocytic leukemia, moderated by Dr Neil Love. Produced by Research To Practice.
-
Optimizing Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer Harboring PI3K/AKT/PTEN Pathway Abnormalities
November 18th, 2024 | Season 1 | 56 mins 48 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the management of HR+ metastatic breast cancer with mutations in PI3K, AKT or PTEN with Drs Jhaveri and Rugo, moderated by Dr Neil Love. Produced by Research To Practice.
-
Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care — Lung Cancer
November 15th, 2024 | Season 1 | 1 hr 5 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring discussions with specialists on optimal management and the potential role of investigational approaches for lung cancer, moderated by Dr Neil Love. Produced by Research To Practice.
-
Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care — Breast Cancer
November 15th, 2024 | Season 1 | 1 hr 3 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring discussions with specialists on optimal management and the potential role of investigational approaches for HR-positive breast cancer, moderated by Dr Neil Love. Produced by Research To Practice.
-
What Clinicians Want to Know About the Current and Future Role of EZH1/2 Inhibitors in the Care of Patients with Lymphoma
November 8th, 2024 | Season 1 | 56 mins 14 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on EZH1/2 inhibitors for the treatment of follicular lymphoma with Dr Gilles Salles, moderated by Dr Neil Love. Produced by Research To Practice.
-
Special Edition — Key Presentations on Lung Cancer from Recent Major Conferences
November 6th, 2024 | Season 1 | 54 mins 39 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on data from recent conference presentations and new approvals in lung cancer with Dr Stephen V Liu, moderated by Dr Neil Love. Produced by Research To Practice.
-
The Implications of Recent Datasets for the Current and Future Management of Gastrointestinal Cancers — An ESMO Congress 2024 Review
November 5th, 2024 | Season 1 | 1 hr 2 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion of GI cancers after the 2024 ESMO annual congress and other conferences, with Drs Bekaii-Saab and Philip, moderated by Dr Neil Love. Produced by Research To Practice.
-
Improving Outcomes with First-Line Endocrine-Based Therapy for Patients with HR-Positive, HER2-Negative Metastatic Breast Cancer
November 1st, 2024 | Season 1 | 59 mins 29 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on first-line therapy for HR-positive, HER2-negative metastatic breast cancer with Prof Bidard and Dr Kalinsky, moderated by Dr Neil Love. Produced by Research To Practice.
-
Practical Perspectives: Optimizing the Role of BTK Inhibitors in the Management of Mantle Cell Lymphoma
October 29th, 2024 | Season 1 | 57 mins 58 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the use of Bruton tyrosine kinase inhibitors for mantle cell lymphoma with Drs Tycel Phillips and Michael Wang, moderated by Dr Neil Love. Produced by Research To Practice.
-
Potential Role of PROTAC ER Degraders in Therapy for HR-Positive Metastatic Breast Cancer
October 25th, 2024 | Season 1 | 45 mins 45 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the optimal management of breast cancer with Dr Erika Hamilton, moderated by Dr Neil Love. Produced by Research To Practice.
-
Practical Perspectives: Current Management of Chronic Myeloid Leukemia
October 23rd, 2024 | Season 1 | 1 hr 49 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the management of chronic myeloid leukemia with Drs Bhatnagar, Blackmon, Cortes, Mauro and Shah, moderated by Dr Neil Love. Produced by Research To Practice.
-
The Implications of Recent Datasets for the Current and Future Management of Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer Review
October 22nd, 2024 | Season 1 | 42 mins 46 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent presentations on small cell lung cancer from the 2024 World Conference on Lung Cancer with Dr Jacob Sands, moderated by Dr Neil Love. Produced by Research To Practice.